Cancer Immunotherapy CONNECT, Powered by SITC


Feedback Invited on the, 
"Society for Immunotherapy of Cancer Consensus Statement on Immunotherapy for the Treatment of Bladder Carcinoma."

Open Comment period ends on Thursday, April 20, 2017, at 5 p.m. ET.
*Available to SITC members current in their dues. Join SITC, renew your membership, or check your current membership status.

Learn More

2017 Advances in Cancer Immunotherapy™ – San Francisco

Join us May 6 in San Francisco, CA for the first Advances in Cancer Immunotherapy™ series program of 2017! Learn basic immunology principles, the mechanisms and clinical applications of immunotherapy for disease states with FDA-approved treatments and more.

Register for San Francisco


Cancer Immunotherapy CONNECT Patient Resources Portal

Visit our patient resources portal to learn the basics of a variety of types of cancer, the immune system and the promise immunotherapy is showing in changing the lives of cancer patients.

Learn More


Join the Discussion! Create a Cancer Immunotherapy CONNECT Account

Learn and share information in the new Cancer Immunotherapy CONNECT Open Forum! Follow a few easy steps to create a free CONNECT account, upload a profile photo and then join the conversation.

Create an Account

Gears No Icons

Welcome to our new community, Cancer Immunotherapy CONNECT

Powered by the Society for Immunotherapy of Cancer, CONNECT is the source and resource for all things cancer immunotherapy. Click the link below to learn more about our exciting new website!


NSCLC Immunotherapy:
Advancing Hope™

Recommended for patients, registered nurses and physicians to promote shared decision making for the patient and cancer care team.

*current as of August 2016

Learn More

Sparkathon Logo

Light the Spark

Support cancer immunotherapy research and ignite the Sparkathon.

Double your donations now through our matching gift challenge. Text "SPARK" to 50555 to donate $25 to the Sparkathon.

Learn More


FOCIS-SITC Cancer Immunity & Immunotherapy Course

June 14 • Hilton Chicago • Chicago, Illinois

This course will review tumor immunology as the foundation of cancer immunotherapy, emphasizing fundamental principles, recent clinical advances, current limitations and opportunities for furthering clinical progress.

Learn More

Clinical Advances in Cancer Immunotherapy Online Portal

In partnership with Medscape Oncology, SITC offers a robust online learning portal designed to provide clinical oncologists with free, CME-/CE-certified education in the immunotherapy field.

Learn More


Explore resources and educational opportunities for cancer patients and those who advocate for them.







Track the latest advancements and educational opportunities in cancer immunotherapy and immunology.







Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.






Latest Discussions

Follow the SITC Twitter Feed.


Connect with colleagues at these Upcoming Events.


Ignite the Sparkathon

Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.


Learn More


Publications & Resources

Journal for ImmunoTherapy of Cancer

An open access, peer-reviewed journal, JITC is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Learn More


Making Cure a Reality

It is the mission of the Society for Immunotherapy of Cancer to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.


Learn More